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Abstract
Background: As aerial parts of Rubus ulmifolius contains phytochemicals like flavonoids and tannins. And whereas
flavonoids and tannins have antioxidant and antipyretic activity, hence, current work is carried out to screen crude
methanolic extract of aerial parts of Rubus ulmifolius (Ru.Cr) and crude flavonoids rich extract of Rubus ulmifolius
(Ru.F) for possible antioxidant and antipyretic activity. Ru.Cr and Ru.F are also tested for brine shrimps lethality
bioassay. Ru.F is tested for the first time for possible antioxidant and antipyretic activity.
Methods: Preliminary phytochemical screening of Ru.Cr and Ru.F was performed as it provides rapid finger
printing for targeting a pharmacological activity. Acute toxicity and Brine shrimps’ cytotoxicity studies of Ru.Cr
and Ru.F were performed to determine its safe dose range. Antioxidant and antipyretic studies were also
performed as per reported procedures.
Results: Ru.Cr tested positive for presence of tannins, alkaloids, flavonoids and steroids. Ru.Cr is safe up to 6 g/kg
following oral doses for acute toxicity study. Ru.Cr is safe up to 75 μg/kg (p.o), LC50 for Ru.Cr and Ru.F are 16.7 ±
1.4 μg/ml 10.6 ± 1.8 μg/ml, respectively (n = 3). Both Ru.Cr and Ru.F demonstrated comparable antioxidant activity
using vitamin C as standard (p ≤ 0.05). In test dose of 300 mg of Ru.Cr, rectal temperature was reduced by 74%
(p ≤ 0.05) on 4th hour of the administration. More, Ru.F produced 72% reduction in pyrexia (p ≤ 0.05) on 4th hour
of administration of paracetamol in Westar rats.
Conclusions: The current work confirms that aerial parts of Rubus ulmifolius contain flavonoids that are safe up to
6 g/kg (p.o). Crude methanolic extract and flavonoids rich fraction of Rubus ulmifolius have significant antioxidant
and antipyretic activity. Further work is required to isolate the pharmacologically active substances for relatively
safe and effective antipyretics and antioxidants.
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Background
Most of the people in world uses medicinal plants for
treatment of different ailments as medicinal plants are
rich source of drugs from natural sources [1]. The genus
Rubus consists of more than 750 species and 12 subgen-
era. The genus is distributed all over the world, except
Antarctica [2, 3]. Uses of Rubus species in folk medicine
is based on its ethno-medicinal uses [4]. Different spe-
cies of genius Rubus synthesize several varieties of
medically active phytochemicals. Most of the phyto-
chemicals are derivatives of phenolics, alkaloids, glyco-
sides and terpenoids. Phenolics are most active
biochemical constituents in species of Rubus [3]. Phe-
nolics of Rubus include potent in vitro antioxidants,
flavonoids, including compounds like flavanones, iso-
flavones, flavones, anthocyanins and catechins [5, 6].
Paste of roots of Rubus ellipticus is used to relieve
severe headache [7]. In folk medicine, Rubus idaeus is
used for treatment of colic pain and wounds in many
countries. Extract of fruits of wild raspberry is used as
diuretic [8]. Fruits of other species like Rubus coreanus
is aphrodisiac, anti-inflammatory [9], anti-bacterial
[10], antioxidant [11], anti-allergic [12] and anticancer
[13] in traditional medicine. Traditionally, Rubus fruti-
cosus has been in use for treatment of skin diseases,
itching, scabies and eczema [14].* Correspondence: niazpharmacist@yahoo.com1Department of Pharmacology, Institute of Basic Medical Sciences, Khyber
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Rubus ulmifolius belongs to family Rosaceae [14]. In
Italian traditional medicines, Rubus ulmifolius, has been
in use for treatment of ulcers, abscesses, furuncles, red
eyes, vaginal disorders, intestinal inflammations, diar-
rhea and hemorrhoids [15]. It is also used as antipyretic
and carminative agent [16]. In Chilean folk medicine,
Rubus ulmifolius is used for hypoglycemic activity [17].
It contains organic acids, ascorbic acid, volatile oils and
tannins [18]. More, it has been reported that Rubus
ulmifolius contains phenolics and flavonoids. Its key
compounds are caffeic acid, ferulic acid, quercetin-3-O-
glucuronide, kaempferol-3-O-β-D-glucuronide, gallic
acid, ferulic acid and tiliroside [19]. Investigations for
safe and effective herbal remedies for potent antipyretic
activity gained momentum in recent as aspirin, para-
cetamol and nimesulide are toxic [20]. Thus safe and
effective antipyretics are the need of time, preferably
from plants’ kingdom. Flavonoids are found in different
types of vegetables and fruits. Nuts, seeds, stems,
flowers, tea, wine and honey are rich sources of flavo-
noids. Common constituents of chief dietary sources
are flavonols, flavones, isoflavones, flavonones and
biflavones [21–23]. Daily flavonoids intake ranges in 1–
2 g/day [24]. On the other hand, flavonols and flavones
daily intake was found as 23 mg, amongst which flavo-
nol quercetin is 16 mg/day [25]. This represents that
flavonoids, in general, are very safe. Flavonoids that
demonstrate well defined structure activity relation-
ships include flavones, flavanones, flavanonols, flavans,
flavonols, catechins, anthocyanidins and isoflavone.
Biological activities of the major flavonoids include
anti-inflammatory, antioxidant, anticancer, antiviral and
antibacterial. It has been reported that flavonoids have
direct cyto-protective effect on coronary and vascular
systems, the liver, and the pancreas. These distinctive
characteristics of flavonoids place them as preferred
phytochemicals amongst the natural products [26].
Rutin, quercetin (flavonols) and hesperidin (flavanone)
have inhibited inflammation. Rutin is used in treatment
of chronic phase of inflammatory arthritis [27]. Simi-
larly, quercetin has been effective in reducing rat paw
edema induced by carrageenan [28]. More, flavonoids
have inhibited the enzymatic activity of cyclooxygenases
and lipoxygenases that ultimately help as anti-
inflammatory and antipyretic [29, 30] activity with de-
crease in inflammatory cytokines [31]. Flavonoids are
very potent antioxidants against free radicals as well.
They are described as free-radical scavengers like rutin
and apigenin [32–35]. Free radical scavenging capacity
is primarily accredited to high reactiveness of their hy-
droxyl substituents that take part in the reaction [25].
Due to their variety of pharmacological activities, flavo-
noids are referred as “nutraceuticals” [33, 36–38]. As
Rubus ulmifolius is rich with flavonoids and phenolics
that have antioxidant effects. In addition, rutin and are
flavonoids that have been reported to have anti-
inflammatory effects by preventing prostaglandins syn-
thesis, hence, in the present investigations, an attempt
has been made to evaluate pharmacological activities of
aerial parts of Rubus ulmifolius on the basis of the
reported phytochemical constituents like flavonoids.
More, there are no reports for pharmacological screen-
ings of total flavonoids of Rubus ulmifolius. Because of
the potential antioxidant and antipyretic activity of fla-
vonoids, we targeted Rubus ulmifolius for possible anti-
pyretic activity. Acute toxicity and brine shrimp
cytotoxicity of the extract as well as of the flavonoids
are also performed to determine its safe dose range.
Methods
Plant materials
Fresh aerial parts of Rubus ulmifolius were collected in
month of August 2012 from Chakdara (Dir Lower),
Khyber Pakhtunkhwa Province of Pakistan. The plant
was identified by Dr. Nasr Ullah Khan. A voucher spe-
cimen RU/023/013 was submitted to the herbarium of
University of Malakand Chakdara, Dir Lower, Khyber
Pakhtunkhwa.
Preparation of crude extract
The collected aerial parts of Rubus ulmifolius were prop-
erly cleaned and subjected to shade drying. The dried
plant materials (6.50 Kg) were mashed to fine powder
using a mechanical grinder. The grinded materials were
soaked in 11 liters of methanol (commercial grade) for
15 days. The soaked plant materials were frequently
shaken and then filtered through Whatman Filter paper.
The process was repeated three times. The filtrates were
combined and concentrated using a rotary evaporator till
a thick gummy and dark greenish crude extract (285.0 g)
of Rubus ulmifolius (Ru.Cr) was obtained.
Preparation of crude flavonoids rich extract
For extraction of crude flavonoids rich extract, shade
dried materials of aerial parts of Rubus ulmifolius
(180 g) were finely powdered through mesh size number
40. The crushed material was filled in thimbles and was
made defatted through uninterrupted hot extraction by
n-hexane. The menstruum was successively extracted
with methanol using Soxhlet apparatus for 12 h till dark-
ish green mass was obtained. The contents were concen-
trated through evaporation. It yielded 27 g of crude
flavonoids rich extract Rubus ulmifolius (Ru.F).
Animals
Albino mice (either sex) weighing in range 25–30 g were
used in acute toxicity screening. Westar rats with aver-
age weight 180–200 g (either sex) were obtained from
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the animal house of University of Malakand, Khyber
Pakhtunkhawa, Pakistan. Rats were used for screening of
antipyretic activity. The animals were treated as per
“Byelaws of the Scientific Procedures Issue-1 (2008) of
University of Malakand”. The animals were kept in dry
and clean cages on temperature 25 ± 3°C with 12h:12h
dark/light cycle; relative humidity of 45–55%. The ani-
mals for the experiments were fasted overnight. How-
ever, they had free access to water. Ethical Committee
of Department of Pharmacy, University of Malakand
accorded approval as per “Byelaws of the Scientific Pro-
cedures Issue-1 (2008) of University of Malakand”.
Statistics
All data are expressed as mean ± standard error of mean
(SEM). Student’s t-test is applied using Graph Pad Prism
with p < 0.05.
Pharmacological activities
Preliminary phytochemical screening
Ru.Cr was exposed to preliminary phytochemical exam-
ination for detection of terpenoids, flavonoids, glyco-
sides, tannins, saponins, alkaloids, phenolic compounds,
proteins, sterols and carbohydrates [39–41]. Similarly,
Ru.F was also tested for flavonoids.
Acute toxicity studies
Either sex Albino mice (weighing 25–30 g) were used
for the evaluation of acute toxicity studies of Ru.Cr and
Ru.F. Acute toxicity studies were conducted in two
phases. Mice were fasted overnight. In phase 1, animals
were allocated into three groups each having 3 mice.
Ru.Cr was administered in test doses in 10, 100 and
1000 mg/kg. The animals were constantly observed for
any behavioral alteration or death toll with follow up for
2 weeks. In 2nd phase, additional three groups, all having
3 mice in each, received doses of 2000, 4000 and 6000
mg/kg of Ru.Cr per oral route, respectively. All animals
were continuously observed for period of 2 weeks for
behavioral changes and death toll.
Same procedure was used to determine the acute tox-
icity studies of Ru.F. Changes in behavior and death toll
were recorded [42].
Brine shrimp cytotoxicity study
Brine shrimp lethality bioassay was performed for as-
sessment of cytotoxic activity of Ru.Cr and Ru.F. A
plastic container which contained filtered artificial sea
water already prepared by the dissolving 38.0 g of sea
salt in 1 liter of distilled water was used in the experi-
ments. Its pH was maintained on 8.5 that promotes the
hatching of Brine shrimp (Artemia salina) eggs [43].
The container was incubated on room temperature for
the next 48 h. After the hatching of eggs, live (larvae)
nauplii which had got separated from the shells were
obtained from the lightened part of compartment.
Then, stock solutions of 10 mg/ml of both crude meth-
anolic and the crude flavonoids extracts of Rubus ulmi-
folius were prepared by dissolving 50 mg of both the
extracts (samples) in 5 ml distilled methanol each.
From the stock solutions, different dilutions i.e. 2.5, 5,
10, 12.5, 25, 50, 75, 100, 250 and 500 μl were prepared
in separate vials and left overnight to evaporate the
solvent. Each vial (after solvent evaporation) was hosted
with ten nauplii (10 brine shrimp larvae) through micro
pipette. Volume in every vial was made with sea water
up to 5 ml. All vials were maintained for 24 h at room
temperature. Numbers of dead and survived shrimps
were counted. The experiments were run in triplicate.
Antioxidant activity
The antioxidant aspect of Ru.Cr and Ru.F were deter-
mined through % scavenging of 2,2-diphenyl-1-picrylhy-
drazyl (DPPH) free radical [44]. Ascorbic acid was
dissolved in methanol to prepare 50 ml of stock solution
in concentration of 500 ppm that served as standard
antioxidant. In the same way, 50 ml of separate stock so-
lutions were prepared for every test sample of Ru.Cr and
Ru.F. Final concentrations of 40, 60, 80, 100 and 200
ppm (5 ml each test samples) were prepared in test
tubes through serial dilutions. To each test tube, 1ml of
stable DPPH was added. The test tubes were incubated
in dark for 30 min at room temperature. Absorbances of
test solutions were measured at 517 nm using UV spec-
trophotometer (Shimadzu UV-1700). Methanol was used
as blank. Percent inhibition or free radical scavenging of
DPPH was determined using following formula:
% inhibition of DPPH




Pyrexia was induced in rats by injecting 20% (20 g of
dried Brewer’s yeast in 100 ml of 2% gum acacia and
0.9% saline aqueous suspension) of Brewer’s yeast in a
dose of 1 ml/100 g body weight (s.c) [45]. The animals
were fasted for 18 h. They had free access to water.
Digital thermometer was used to record rectal
temperature of test animals. Rats with a temperature rise
of at least 0.5 °C to 1 °C were included in the study. Ani-
mals were divided into six groups (GI - GVI) having 6
rats in each group. The GI served as negative control
group, which received 2% gum acacia (p.o). GII repre-
sented the standard group and received paracetamol
(33 mg/kg of body weight in 2% gum acacia) (p.o). GIII
and GIV received 150 mg/kg and 300 mg/kg body
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weight of Ru.Cr (p.o). While GV and GVI received 150
mg/kg and 300 mg/kg body weight of Ru.F (p.o), re-
spectively. Rectal temperature of the animals was noted
on an hour interval for 4 h following the administration
of paracetamol and the test samples. Decrease in rectal
body temperature of test animals was calculated by the
following formula [46]:
Percentage reduction in pyrexia ¼ B‐Cn
B‐A
 100
A =Normal body temperature.
B = Rectal temperature at 18th h after yeast administration.
Cn = Rectal temperature after administration of drug.
Results and discussion
Preliminary phytochemical screening
Results for the presence of different phytochemicals are
mentioned in Table 1. It tested positive for the presence
of flavonoids, alkaloids, tannins, saponins, glycosides,
phenolic compounds, sterols, carbohydrates, terpenoids
and proteins.
Acute toxicity studies
The purpose of acute toxicity studies is to determine a
safe dose range which can be extrapolated to human
model [47]. No death toll was observed till the max-
imum oral dose (6000 mg/kg) of Ru.Cr and Ru.F in all
test groups. These results suggest that Ru.Cr and Ru.F
are safe up to 6000 mg/kg body weight per oral route.
Because of high margin of safety in acute toxicity study,
we selected 150 mg/kg and 300 mg/kg oral doses for
possible in vivo antipyretic activity.
Brine shrimp cytotoxicity study
The effects of Ru.Cr and Ru.F on brine shrimps for pos-
sible lethality are shown in Table 2.
The magnitude of lethality was directly proportional to
the concentration of test samples. Ru.Cr has an LC50 of
16.7 ± 1.4 μg/ml. LCmax∞100% was in concentration of
100 μg/ml. Similarly, Ru.F has an LC50 of 10.6 ±
1.8 μg/ml with maximum mortality in concentration
of 75 μg/ml i.e. LCmax∞100%. This explains that the fla-
vonoids rich extract may have cytotoxic constituents
as well. This study justifies that the plant may be a po-
tential source for isolation of anticancer bioactive
molecules as there are reports that correlate simple
bench‐top bioassays and human tumour cell cytotoxic-
ities as potential antitumor agents [48, 49]. This needs
for isolation of bioactive molecules as plants are good
sources of anticancer drugs.
Antioxidant activity
Results of antioxidant activity of Ru.Cr and Ru.F are
shown in Table 3.
Ru.Cr showed 59.4 ± 0.073% inhibition in concentra-
tion of 40 ppm and 74.2 ± 0.324% inhibition in concen-
tration of 200 ppm. Percent scavenging activity of
ascorbic acid was 87.26 ± 0.128%. Free radical scavenging
with Ru.F is 61.43 ± 0.256% in concentration of 40 ppm.
Ascorbic acid inhibited the free radical scavenging activ-
ity up to 62.7 ± 0.291%. More, in highest concentration
Table 1 Results of different phytochemicals present in
Rubus ulmifolius
S. No. Phytochemicals Results
1 Flavonoids Positive








Table 2 Brine shrimp cytotoxicity assay of test samples of Rubus
ulmifolius
Conc. (μg/ml) Number of
Brine shrimps
Brine shrimps killed (Mean ± SD, n = 3)
Ru.Cr Ru.F
Negative Control 10 00 00
2.5 10 3 ± 0.47 3.23 ± 0.27
5 10 3.33 ± 0.27 4.11 ± 0.27
10 10 4 ± 0 .47* 5 ± 0 .47**
12.5 10 5 ± 0.27** 7.33 ± 0.54***
25 10 6.36 ± 0.27** 9.33 ± 0.27***
50 10 7.42 ± 0.27*** 9.66 ± 0.27***
75 10 9.33 ± 0.27 All dead
100 10 All dead All dead
250 10 All dead All dead
500 10 All dead All dead
LC50 (μg/ml) 16.7 ± 1.4 10.6 ± 1.8
All values are taken as mean ± SD, **P < 0.05, ***P < 0.01
Table 3 Antioxidant activity of Rubus ulmifolius
Conc.
(ppm)
% scavenging of stable DPPH free radical
Ascorbic acid (Control) Ru.Cr Ru.F
40 62.70 ± 0.291 59.4 ± 0.073*** 61.43 ± 0.256***
60 69.96 ± 0.522 61.96 ± 0.259*** 68.61 ± 0.262***
80 75.03 ± 0.328 66.10 ± 0.275** 73.20 ± 0.233***
100 81.26 ± 0.233 71.26 ± 0.321*** 79.38 ± 0.298***
200 87.26 ± 0.128 74.2 ± 0.324*** 83.16 ± 0.091***
All values are taken as mean ± SEM (n = 3), **P < 0.05, ***P < 0.01
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(200 ppm), Ru.F showed 83.16 ± 0.091% free radical
scavenging activity. While ascorbic acid demonstrated
87.26 ± 0.128% free radical scavenging activity. This
shows that the free radical scavenging activity of Ru.F is
comparable with ascorbic acid, a standard antioxidant.
In basic process of oxidation, the most important step is
the formation of free radicals (having unpaired electrons)
in living systems, drugs and even food [50]. Free radicals,
which are extremely unstable, causes many diseases of
kidney and liver, Alzheimer’s disease, fibrosis, cardiac re-
perfusion abnormalities, atherosclerosis, cancer, arthritis,
neurodegenerative disorders and aging [51].
It is reported that antioxidants prevent the oxidative
damage which is caused by reactive oxygen species
(ROS) and free radicals [52]. Antioxidants act by inter-
fering in the oxidation process reaction with the chelat-
ing, catalytic metals and free radicals as oxygen
scavengers [53, 54]. Ru.Cr and Ru.F produced compar-
able free radical scavenging activities both in low and
high concentrations versus standard ascorbic acid. The
order of free radical scavenging of test samples (40 and
200ppm) and standard is: ascorbic acid > Ru. F > Ru.Cr.
Our findings confirm reports that Rubus species are
extremely abundant with phenolic contents like flavo-
noids, phenolic acids and anthocyanins. These phenolic
compounds have been reported to possess antioxidant,
anti-inflammatory and anticancer properties [55].
Amongst different species of genus Rubus, Rubus ellipti-
cus has exhibited antioxidant activities [56]. Rubus cor-
eanus is reported to have antioxidant properties [57]. It
has been reported that the phenolic compounds like flavo-
noids exhibited prominent antioxidant activities [58].
Based on reports for importance of phenolic components
as antioxidants, the observed antioxidant activity may be
attributed to the occurrence of flavonoids like active con-
stituents which require further research for isolation of
antioxidant components from the Rubus ulmifolius.
Antipyretic studies
Both Ru.Cr and Ru.F demonstrated significant antipyr-
etic as mentioned in Table 4. Antipyretic effects are
comparable with antipyretic effects of paracetamol, a
standard antipyretic agent.
Ru.Cr in test dose of 300 mg reduced rectal
temperature up to 74% on 4th hour of the administra-
tion. On 3rd hour, Ru.Cr decreased body temperature by
58%. Similarly, Ru.F produced 72% reduction in body
temperature on 4th hour of the administration. Following
2nd hour of administration of Ru.F, decrease in body
temperature was 59%, which is 52% of paracetamol, a
standard antipyretic. This suggests that Ru.Cr and Ru.F
have antipyretic activity. Antipyretic drugs are used to
reduce the elevated body temperature both by depres-
sion of inflammatory mediators at sites of peripheral tis-
sues, and at thermoregulatory sites within the Central
Nervous System (CNS) [59]. NSAIDs are having antipyr-
etic action due to their inhibitory effects on cyclooxy-
genase (COX), an enzyme responsible for production of
prostaglandins, which are important mediators for pro-
ducing pain and pyrexia. NSAIDs are said to possess
antipyretic properties which resets the hypothalamic
thermostat and thus reduces elevated body temperature
during fever. Heat loss is promoted by cutaneous vaso-
dilatation and sweating. Paracetamol produces anti-
pyretic action while acting on CNS [60].
Yeast administration induces the release of phagocytes
and interleukins (endogenous Pyrogens). Interleukins
helps the production of T-lymphocytes, which in turn
induce - hypothalamus to produce prostaglandins that
finally elevate the body temperature [61].
In a test dose of 300 mg, it is evident that Ru.F
produced 85.83% fall in body temperature. These re-
sults confirm that the crude methanolic extract and
crude flavonoids rich extract of Rubus ulmifolius
have significant antipyretic effect. This significant
antipyretic effect of Rubus ulmifolius is attributed to
the presence of phytochemicals like flavonoids,
which are reported for inhibitory effects on cycloox-
ygenases [62, 63]. The flavonoids are known to act
by blocking the synthesis of prostaglandins E2 pre-
dominantly through inhibition of prostaglandins syn-
thetase enzyme [64]. Hence, it is deduced that the
Table 4 Effect of crude and flavonoids extracts of Rubus ulmifolius on yeast-induced pyrexia in Rats
Groups Rectal Temperature in °C
Normal Brewer’s
yeast
After administration of test samples and standard drug
1sthr 2ndhr 3rdhr 4thhr
GI (Control) 37.36 ± 0.08 39.61 ± 0.03 39.41 ± 0.04 (8.88%) 39.48 ± 0.06 (5.92%) 39.43 ± 0.07 (8.14%) 39.46 ± 0.04 (6.66%)
GII (Paracetamol) 37.46 ± 0.04 39.4 ± 0.06 38.86 ± 0.08 (27.58%) 38.38 ± 0.07 (52.58%) 38 ± 0.05*** (72.41%) 37.7 ± 0.05*** (87.93%)
Ru.Cr GIII 150 mg 37.13 ± 0.03 39.45 ± 0.24 39.36 ± 0.08 (3.87%) 39.10 ± 0.15 (15.08%) 38.76 ± 0.23 (29.74%) 38.20 ± 0.11* (53.87%)
GIV 300 mg 37.23 ± 0.08 38.90 ± 0.30 38.71 ± 0.08 (11.37%) 38.36 ± 0.34 (32.33%) 37.93 ± 0.42** (58.08%) 37.66 ± 0.38*** (74.25%)
Ru.F GV 150 mg 37.16 ± 0.08 39.36 ± 0.38 38.84 ± 0.12 (23.63%) 38.71 ± 0.35 (29.54%) 38.53 ± 0.12 (37.72%) 37.87 ± 0.50** (67.72%)
GVI 300 mg 37.26 ± 0.12 39.66 ± 0.20 38.70 ± 0.45 (40%) 38.23 ± 0.08** (59.58%) 37.86 ± 0.18*** (75%) 37.60 ± 0.05*** (85.83%)
All values are taken as mean ± SEM (n = 3), **P < 0.05, ***P < 0.01
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antipyretic effects may be attributed to flavonoids
present in the species.
Thus, the present study confirms the folkloric use of
Rubus ulmifolius as antipyretic remedy. However, further
studies are suggested to isolate the pharmacologically ac-
tive antipyretic constituents from the species.
Conclusions
The current work confirms that aerial parts of Rubus
ulmifolius contain flavonoids that are safe up to 6g/kg
(p.o). Crude methanolic extract and flavonoids rich frac-
tion of Rubus ulmifolius have significant antioxidant and
antipyretic activity. Further work is required to isolate
the pharmacologically active substances for relatively
safe and effective antipyretics and antioxidants.
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